Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-19

Clinical Trial Update: Preemptive Analgesia for Primary Dysmenorrhoea [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trial update for preemptive analgesia in primary dysmenorrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hanan Nabil | Conditions: Primary Dysmenorrhea | Phase 2, Phase 3 | Status: COMPLETED